Olpaza 150mg Tablet 30’s

Product Details

Olpaza 150mg Tablet contains the active ingredient olaparib, a PARP (poly ADP ribose polymerase) inhibitor that is primarily used in the treatment of BRCA-mutated cancers, including ovarian, breast, pancreatic, and prostate cancers. Olpaza works by blocking PARP enzymes, which are involved in DNA repair in cancer cells. By inhibiting this repair mechanism, Olpaza promotes the death of cancer cells and helps control tumor growth, particularly in cancers with defective DNA repair pathways.

Uses:

• Treatment of BRCA-mutated ovarian cancer in adults
• Management of BRCA-mutated breast cancer
• Treatment of metastatic pancreatic cancer with BRCA mutations
• Effective for advanced prostate cancer with BRCA mutations

Side Effects:

• Common side effects: fatigue, nausea, vomiting, loss of appetite, and anemia.
• Serious side effects: blood disorders like myelodysplastic syndrome (MDS), acute myeloid leukemia (AML), and severe lung inflammation. Patients should seek medical attention if they experience persistent fever, unexplained bruising, or breathing difficulties.

Key Features:

• Contains olaparib, a targeted PARP inhibitor for cancer treatment.
• Specifically designed for patients with BRCA-mutated cancers.
• Prevents DNA repair in cancer cells, promoting cancer cell death.
• Oral tablet form allows for convenient dosing at home.

FAQ:

1. How does Olpaza 150mg Tablet work in cancer treatment?
   Olpaza blocks the PARP enzyme, which is essential for DNA repair in cancer cells. By inhibiting DNA repair, Olpaza encourages cancer cell death and limits tumor growth.
2. Who can use Olpaza?
   Olpaza is indicated for patients with BRCA-mutated ovarian, breast, pancreatic, and prostate cancers, as confirmed by genetic testing and a doctor’s recommendation.
3. What precautions should I take while on Olpaza?
   Patients should have regular blood tests to monitor for blood cell abnormalities and should inform their healthcare provider about any unusual symptoms like unexplained bruising or fatigue.

References:

1. Olaparib) tablets, for oral use.” U.S. Food and Drug Administration : https://en.wikipedia.org/wiki/Olaparib
2. Webmd . Available from: https://www.webmd.com/drugs/2/drug-167493-1856/lynparza-oral/olaparib-tablet-oral/details